These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3579928)

  • 21. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(6):567-72. PubMed ID: 12866710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF.
    Moser A; Kömpf D
    Life Sci; 1992; 50(24):1885-91. PubMed ID: 1598074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's Disease.
    Soto-Otero R; Riguera-Vega R; Méndez-Alvarez E; Sánchez-Sellero I; López-Rivadulla Lamas M
    Biochem Biophys Res Commun; 1996 May; 222(2):607-11. PubMed ID: 8670252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry in Parkinson's disease.
    Niwa T
    Clin Chim Acta; 1995; 241-242():223-50. PubMed ID: 8612340
    [No Abstract]   [Full Text] [Related]  

  • 25. Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain.
    DeCuypere M; Lu Y; Miller DD; LeDoux MS
    J Neurochem; 2008 Dec; 107(5):1398-413. PubMed ID: 19013830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoquinoline neurotoxins in the brain and Parkinson's disease.
    Nagatsu T
    Neurosci Res; 1997 Oct; 29(2):99-111. PubMed ID: 9359458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of Parkinson's disease-causing mechanism and development of anti-Parkinson's disease drugs using endogenous substances in brain].
    Ohta S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Feb; 25(1):39-42. PubMed ID: 15796069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous synthesis of N-methylnorsalsolinol in rat brain during in vivo microdialysis with epinine.
    Kajita M; Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Watanabe K; Naoi M; Nagatsu T
    J Chromatogr B Biomed Appl; 1994 Apr; 654(2):263-9. PubMed ID: 8044287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.
    Suzuki K; Mizuno Y; Yamauchi Y; Nagatsu T; Mitsuo Y
    J Neurol Sci; 1992 Jun; 109(2):219-23. PubMed ID: 1353109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
    Soto-Otero R; Méndez-Alvarez E; Sánchez-Sellero I; Cruz-Landeira A; López-Rivadulla Lamas M
    Neurosci Lett; 2001 Feb; 298(3):187-90. PubMed ID: 11165438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxins: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1,2,3,4-tetrahydroisoquinoline and 1-methyl-6,7-dihydroxy-tetrahydroisoquinoline as substrates for FAD-containing monooxygenase of porcine liver microsomes.
    Wu RF; Miura S; Ichikawa Y
    Biochem Pharmacol; 1992 Nov; 44(10):2079-81. PubMed ID: 1449525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of noradrenergic system in the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies.
    Michaluk J; Krygowska-Wajs A; Karolewicz B; Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(1):19-25. PubMed ID: 12020040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventative effects of 1,3-dimethyl- and 1,3-dimethyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on MPTP-induced Parkinson's disease-like symptoms in mice.
    Katagiri N; Chida S; Abe K; Nojima H; Kitabatake M; Hoshi K; Horiguchi Y; Taguchi K
    Brain Res; 2010 Mar; 1321():133-42. PubMed ID: 20114039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.
    Kotake Y; Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1995 Dec; 65(6):2633-8. PubMed ID: 7595560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.
    Suzuki K; Mizuno Y; Yoshida M
    Adv Neurol; 1990; 53():215-8. PubMed ID: 2122645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 1-cyclohexyl- and 1-cyclohexyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on dopaminergic spontaneous discharge in nigral neurons of rats.
    Abe M; Munakata H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
    Brain Res Bull; 2016 Mar; 121():201-8. PubMed ID: 26876935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.
    Yamakawa T; Kotake Y; Fujitani M; Shintani H; Makino Y; Ohta S
    Neurosci Lett; 1999 Nov; 276(1):68-70. PubMed ID: 10586977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
    J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.